PCSK9 and obesity due to melanocortin 4 receptor deficiency: In patients with stable CAD, low plasma levels of PCSK9 were linked with a particular metabolic phenotype (low HDL-C, the metabolic syndrome, obesity, insulin resistance and DM) [19].